OVARIAN CANCER

China news agency, Sydney, September 19-House in Perth, Western Australia's University of Science and Technology Keding a latest study, a Gallup poll green tea can prevent ovarian cancer, and may help to prolong the women with ovarian cancer life.

As past research shows that green tea help prevent ovarian cancer, researchers at the University of Technology Keding also on 254 with ovarian cancer in Chinese women were studied.
The new study found that women with ovarian cancer, drinking green tea to die of the disease risk to drink green tea are less than half; A Gallup poll of green tea with the women of ovarian cancer, died from the disease, the risk is reduced 60%.

Tags: age, cancer, ert, green, growth, life, ovarian, patients, reduce, risk, study, tea, women

Ovarian cancer

Tags: abdominal, age, benign, bleeding, blood, body, cancer, cause, cell, cells, clinical, cyst, examination, fat, growth, head, malignant, mass, ovarian, pain, second, symptoms, tumor, tumors, women

Ovarian cancer

Tags: age, annex, blood, body, cancer, cases, cell, cells, chemotherapy, clinical, cyst, cystic, diagnosis, drug, drugs, early, eat, examination, fat, mass, method, ovarian, pain, patients, pelvic, poor, prognosis, reduce, resection, study, surgical, symptoms, therapy, time, toxicity, treatment, tumor, tumors, women

Disease Overview

Tags: age, breast, cancer, carcinoma, cause, cell, cells, chemotherapy, children, diagnosis, early, eat, ert, fat, gene, group, incidence, increased, knowledge, life, lymph, malignant, metastatic, ovarian, patients, preventive, radiotherapy, rate, risk, second, surface, surgery, survival, symptoms, tea, therapy, time, treatment, tumor, tumors, uterine, women

You are interested in the manual open to learning the prevention and treatment of ovarian cancer, you may answer the following questions, which are from the United States, 199 by the latest knowledge of ovarian cancer questionnaire. Facts have proved that the developed countries in Europe and the United States these people are aware of ovarian cancer rarely. Gynecologic Oncology experts say: lack of knowledge of ovarian cancer is the cause of ovarian cancer mortality leapt to the forefront of gynecologic cancer mortality one of the major reasons. How do you these basic knowledge of the number of ovarian cancer?

Tags: abdominal, age, blood, body, breast, cancer, cause, cell, diagnosis, early, eat, ert, examination, family, gene, growth, gynecological, history, incidence, knowledge, life, lymph, metastasis, method, node, ovarian, ovary, pain, patients, pelvic, rate, reduce, risk, screening, survival, symptoms, time, treatment, tumor, tumors, women, wrong

Basic symptoms: early ovarian cancer usually no obvious symptoms, if there is non-specific symptoms, such as menstrual disorder, mild gastrointestinal discomfort. With the growth of tumors may arise under bloating, discomfort, or sometimes because of oppression involved in the bladder or rectum and frequency, diarrhea, constipation,. More advanced symptoms from ascites, omental or metastatic gastrointestinal such as abdominal distension, shortness of breath, abdominal discomfort, and incomplete intestinal obstruction or even obstructive symptoms. Part of mesenchymal tumors or tumor invasion of genistein and uterus can cause irregular vaginal bleeding. If a tumor metastasis may have different performance of the corresponding organ involvement.

Tags: abdominal, age, bleeding, blood, cancer, cause, cell, chemotherapy, cyst, cystic, diagnosis, early, eat, ert, examination, gene, grams, growth, gynecological, injection, knowledge, malignant, mass, metastasis, metastatic, oppression, ovarian, patients, pelvic, prognosis, radiotherapy, residual, screening, staging, surgery, symptoms, therapy, time, treatment, tumor, tumors, usually

Epithelial ovarian cancer in the United States is a relatively rare in Gynecologic Oncology, 2004, there were approximately 25,580 cases of new onset patients, 16,090 cases patients died. The majority of patients with advanced cancer, treatment for surgical resection and postoperative to platinum-based chemotherapy. During the past 10 years, chemotherapy improved survival rates improve, and recurrent tumor treatment more effective. In addition, the genetic risk factors for making in-depth understanding of the prevention strategy to become individualized approach to bilateral tubal women - ovarian surgery. This report summarized the clinical characteristics of epithelial ovarian, after reports focus on the treatment of the latest developments.

Tags: age, brca1, breast, cancer, carcinoma, cases, cause, chemotherapy, clinical, diagnosis, drug, drugs, early, eat, ert, estrogen, examination, family, gene, group, groups, history, incidence, increased, life, malignant, mutation, ovarian, ovary, patients, pelvic, preventive, protein, rate, reduce, resection, risk, screening, second, study, surface, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, usually, women

Amenorrhea is common clinical symptoms, their causes are complex, the causes can be divided into the central nervous system and the hypothalamus, pituitary, ovary and uterus of amenorrhea, including congenital Gonadal Dysgenesis and autoimmune ovarian inflammation. As such closure gonadotropin levels often associated with higher estrogen levels decrease, it said hypergonadotropic amenorrhea, gonadotropin levels higher than normal cycle or reached menopause, clinical manifestations of primary or secondary amenorrhea.

Tags: age, amenorrhea, anti, blood, body, cause, clinical, diagnosis, eat, ert, estrogen, examination, gene, ovarian, ovary, patients, pelvic, poor, positive, rate, second, symptoms, time, treatment

One, paclitaxel and cisplatin in the treatment of advanced ovarian cancer care <BR> <BR> 1990s Taxol is more of the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.

One, information and Methods

Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, confidence, days, diet, dose, drug, drugs, eat, ert, estrogen, family, fat, gene, group, growth, incidence, infusion, injection, intravenous, life, mass, metastasis, method, ovarian, paclitaxel, pain, patients, physical, poor, positive, psychological, quality, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, women

I. Overview

With the aging of the global trend of development, improve the economic status of women, more and more women start hormone replacement therapy (Hormone Replacement Therapy, HRT), to improve access to after menopause due to the decrease in the level of sex hormones related to various diseases. Clear evidence that: postmenopausal women with age, the incidence of coronary heart disease increased by about four times the fracture due to osteoporosis by 20%, died of complications due to pelvic fracture rate of 30%, after the 65-year-old Alzheimer's incidence rate increase every year <BR> and Application HRT can peer groups coronary heart disease risk 50% Alzheimer's risk reduced three times, especially worth mentioning is significantly reduced the incidence of rectal cancer. Long-term use of HRT cancer risk reduced year by year. HRT can also greatly improve the menopause, postmenopausal women with disease or ovarian surgery, radiotherapy in patients with a series of artificial menopause syndrome.

Tags: age, benign, blood, body, brca1, breast, cancer, carcinoma, care, cases, cause, cell, cells, clinical, cyst, cystic, diagnosis, diet, drug, early, eat, ert, estrogen, family, fat, gene, grams, group, groups, growth, gynecological, history, hrt, incidence, increased, injection, intravenous, life, lymph, malignant, metastasis, method, mutation, node, ovarian, patients, pelvic, positive, protein, quality, radiotherapy, rate, reduce, residual, risk, screening, second, study, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, tumors, usually, uterine, women